Immediate Impact
66 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Ponsegromab for the Treatment of Cancer Cachexia
2024 Standout
Works of L M Forrest being referenced
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
2004
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
2003 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| L M Forrest | 1164 | 228 | 468 | 392 | 9 | 1.6k | |
| Colin D. Fletcher | 1036 | 134 | 310 | 406 | 42 | 1.9k | |
| N. Haboubi | 859 | 107 | 291 | 611 | 29 | 1.6k | |
| G Kosaki | 749 | 390 | 466 | 628 | 22 | 1.4k | |
| J E M Crozier | 855 | 109 | 218 | 368 | 14 | 1.2k | |
| Tokio Onodera | 730 | 392 | 446 | 627 | 8 | 1.4k | |
| Khalid Canna | 1120 | 94 | 349 | 462 | 14 | 1.4k | |
| Juan C. Gutierrez | 752 | 106 | 816 | 479 | 31 | 1.9k | |
| Graeme J.K. Guthrie | 1171 | 85 | 301 | 337 | 29 | 1.5k | |
| G. Lennard Gold | 682 | 66 | 388 | 193 | 15 | 1.4k | |
| James B. Gerstner | 1538 | 169 | 533 | 301 | 29 | 2.1k |
All Works
Loading papers...